{"pmid":32419177,"title":"Collateral damage of COVID-19 pandemic: Delayed medical care.","text":["Collateral damage of COVID-19 pandemic: Delayed medical care.","During the COVID-19 pandemic, emergency room visits have drastically decreased for non-COVID conditions such as appendicitis, heart attack, and stroke. Patients may be avoiding seeking medical attention for fear of catching the deadly condition or as an unintended consequence of stay-at-home orders. This delay in seeking care can lead to increased morbidity and mortality, which has not been figured in the assessment of the extent of damage caused by this pandemic. This case illustrates an example of \"collateral damage\" caused by the COVID-19 pandemic. What would have been a standard ST-elevation myocardial infarction treated with timely and successful stenting of a dominant right coronary artery occlusion, became a much more dangerous postinfarction ventricular septal defect; all because of a 2-day delay in seeking medical attention by an unsuspecting patient.","J Card Surg","Masroor, Saqib","32419177"],"abstract":["During the COVID-19 pandemic, emergency room visits have drastically decreased for non-COVID conditions such as appendicitis, heart attack, and stroke. Patients may be avoiding seeking medical attention for fear of catching the deadly condition or as an unintended consequence of stay-at-home orders. This delay in seeking care can lead to increased morbidity and mortality, which has not been figured in the assessment of the extent of damage caused by this pandemic. This case illustrates an example of \"collateral damage\" caused by the COVID-19 pandemic. What would have been a standard ST-elevation myocardial infarction treated with timely and successful stenting of a dominant right coronary artery occlusion, became a much more dangerous postinfarction ventricular septal defect; all because of a 2-day delay in seeking medical attention by an unsuspecting patient."],"journal":"J Card Surg","authors":["Masroor, Saqib"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32419177","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/jocs.14638","keywords":["covid-19","coronary artery disease","postinfarction ventricular septal defect"],"topics":["Case Report"],"weight":1,"_version_":1667159284480212992,"score":9.490897,"similar":[{"pmid":32444504,"title":"Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemic.","text":["Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemic.","Ischaemic heart disease (IHD), in particular acute coronary syndrome (ACS), comprising ST-elevation myocardial infarction, non-ST-elevation myocardial infarction and unstable angina, is the leading cause of death worldwide. Age is a major predictor of adverse outcome following ACS. COVID-19 infection seems to escalate the risk in older patients with heart disease. Increasing odds of in-hospital death is associated with older age following COVID-19 infection. Importantly, it seems older patients with comorbidities such as cardiovascular disease (CVD), in particular IHD, diabetes and hypertension, are at the highest risk of mortality following COVID-19 infection. The evidence is sparse on the optimal care of older patients with ACS with lack of robust randomised controlled trials. In this setting, with the serious threat imposed by the COVID-19 pandemic in the context of rapidly evolving knowledge with much unknown, it is important to weigh the risks and benefits of treatment strategies offered to older patients. In cases where risks outweigh the benefits, it might not be an unreasonable option to treat such patients with a conservative or a palliative approach. Further evidence to elucidate whether invasive management is beneficial in older patients with ACS is required out-with the COVID-19 pandemic. Though it is hoped that the actual acute phase of COVID-19 infection will be short lived, it is vital that important clinical research is continued, given the long-term benefits of ongoing clinical research for patients with long-term conditions, including CVD. This review aimed to evaluate the challenges and the management strategies in the care of older patients presenting with ACS in the context of the COVID-19 pandemic.","Heart","Rowland, Ben","Kunadian, Vijay","32444504"],"abstract":["Ischaemic heart disease (IHD), in particular acute coronary syndrome (ACS), comprising ST-elevation myocardial infarction, non-ST-elevation myocardial infarction and unstable angina, is the leading cause of death worldwide. Age is a major predictor of adverse outcome following ACS. COVID-19 infection seems to escalate the risk in older patients with heart disease. Increasing odds of in-hospital death is associated with older age following COVID-19 infection. Importantly, it seems older patients with comorbidities such as cardiovascular disease (CVD), in particular IHD, diabetes and hypertension, are at the highest risk of mortality following COVID-19 infection. The evidence is sparse on the optimal care of older patients with ACS with lack of robust randomised controlled trials. In this setting, with the serious threat imposed by the COVID-19 pandemic in the context of rapidly evolving knowledge with much unknown, it is important to weigh the risks and benefits of treatment strategies offered to older patients. In cases where risks outweigh the benefits, it might not be an unreasonable option to treat such patients with a conservative or a palliative approach. Further evidence to elucidate whether invasive management is beneficial in older patients with ACS is required out-with the COVID-19 pandemic. Though it is hoped that the actual acute phase of COVID-19 infection will be short lived, it is vital that important clinical research is continued, given the long-term benefits of ongoing clinical research for patients with long-term conditions, including CVD. This review aimed to evaluate the challenges and the management strategies in the care of older patients presenting with ACS in the context of the COVID-19 pandemic."],"journal":"Heart","authors":["Rowland, Ben","Kunadian, Vijay"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32444504","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/heartjnl-2020-317011","keywords":["acute coronary syndromes","cardiac catheterisation and angiography","coronary artery disease"],"topics":["Prevention"],"weight":1,"_version_":1667600475899297792,"score":170.45288},{"pmid":32337148,"pmcid":"PMC7179991","title":"Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial Infarction.","text":["Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial Infarction.","Patients with Covid-19 disease commonly present with symptoms related to respiratory illness, and less commonly they develop cardiovascular complications either on presentation or during the course of the disease. The mortality/morbidity is high in these patients with cardiovascular involvement. Acute ST-elevation myocardial infarction (STEMI) is a medical emergency which needs immediate coronary re-perfusion for better patient outcomes. Here we present a patient who presented to the emergency room with acute STEMI and later tested positive for COVID-19. She was successfully treated with coronary revascularization and stent placement, and remains on the ventilator to date as she quickly developed acute respiratory distress syndrome. We need more research in Covid-19 patients with cardiovascular involvement for early diagnosis, prevention of exposure to health care workers and effective treatment.","Cureus","Siddamreddy, Suman","Thotakura, Ramakrishna","Dandu, Vasuki","Kanuru, Sruthi","Meegada, Sreenath","32337148"],"abstract":["Patients with Covid-19 disease commonly present with symptoms related to respiratory illness, and less commonly they develop cardiovascular complications either on presentation or during the course of the disease. The mortality/morbidity is high in these patients with cardiovascular involvement. Acute ST-elevation myocardial infarction (STEMI) is a medical emergency which needs immediate coronary re-perfusion for better patient outcomes. Here we present a patient who presented to the emergency room with acute STEMI and later tested positive for COVID-19. She was successfully treated with coronary revascularization and stent placement, and remains on the ventilator to date as she quickly developed acute respiratory distress syndrome. We need more research in Covid-19 patients with cardiovascular involvement for early diagnosis, prevention of exposure to health care workers and effective treatment."],"journal":"Cureus","authors":["Siddamreddy, Suman","Thotakura, Ramakrishna","Dandu, Vasuki","Kanuru, Sruthi","Meegada, Sreenath"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32337148","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.7759/cureus.7782","keywords":["acute respiratory distress syndrome","atypical covid","covid-19","stemi"],"topics":["Case Report"],"weight":1,"_version_":1666138494275158017,"score":165.39711},{"pmid":32352633,"title":"Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients.","text":["Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients.","Important health resources are dedicated worldwide to the management of COVID-19. This new disease, due to its large diffusion, may significantly hamper the prognosis of other pathologies, such as ST-segment elevation myocardial infarction (STEMI) because of (a) a possible direct negative impact and (b) shortage of first response medical resources and increased delays to reperfusion. We report the case of a 68-year-old man admitted for anterior STEMI and asymptomatic COVID-19. Due to extended transportation delays to a cathlab, he received intravenous fibrinolytic therapy, which failed. Reperfusion was achieved with rescue coronary angioplasty, but the patient experienced two episodes of acute stent thrombosis at 2- and 36-hr following admission and despite optimal medical therapy. He finally died because of cardiogenic shock. This raises concerns about a possible increase in platelet aggregability associated with COVID-19 leading to an increased risk of stent thrombosis, particularly in the context of STEMI. This pleads for the promotion of primary coronary angioplasty as the first-choice revascularization technique in this population and the use of new generation P2Y12 inhibitors. In addition, the use of GPIIb/IIIa inhibitors may be considered in every STEMI patient with COVID-19 to prevent the risk of acute stent thrombosis.","Catheter Cardiovasc Interv","Lacour, Thibaud","Semaan, Carl","Genet, Thibaud","Ivanes, Fabrice","32352633"],"abstract":["Important health resources are dedicated worldwide to the management of COVID-19. This new disease, due to its large diffusion, may significantly hamper the prognosis of other pathologies, such as ST-segment elevation myocardial infarction (STEMI) because of (a) a possible direct negative impact and (b) shortage of first response medical resources and increased delays to reperfusion. We report the case of a 68-year-old man admitted for anterior STEMI and asymptomatic COVID-19. Due to extended transportation delays to a cathlab, he received intravenous fibrinolytic therapy, which failed. Reperfusion was achieved with rescue coronary angioplasty, but the patient experienced two episodes of acute stent thrombosis at 2- and 36-hr following admission and despite optimal medical therapy. He finally died because of cardiogenic shock. This raises concerns about a possible increase in platelet aggregability associated with COVID-19 leading to an increased risk of stent thrombosis, particularly in the context of STEMI. This pleads for the promotion of primary coronary angioplasty as the first-choice revascularization technique in this population and the use of new generation P2Y12 inhibitors. In addition, the use of GPIIb/IIIa inhibitors may be considered in every STEMI patient with COVID-19 to prevent the risk of acute stent thrombosis."],"journal":"Catheter Cardiovasc Interv","authors":["Lacour, Thibaud","Semaan, Carl","Genet, Thibaud","Ivanes, Fabrice"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352633","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/ccd.28948","keywords":["acute myocardial infarction","antithrombotic treatment","viral infection"],"topics":["Case Report"],"weight":1,"_version_":1666138495758893056,"score":164.6956},{"pmid":32383284,"title":"Spontaneous coronary artery dissection of the left anterior descending artery in a patient with COVID-19 infection.","text":["Spontaneous coronary artery dissection of the left anterior descending artery in a patient with COVID-19 infection.","A 48-year-old woman with a past medical history of migraines and hyperlipidemia presented due to severe retrosternal chest pain with no other associated signs or symptoms. The patient was hemodynamically stable and was found to have an elevated troponin with electrocardiogram showing no ischemic changes. Computed tomography of the coronary arteries showed a left dominant system with dissection extending from the mid-to-distal left anterior descending (LAD) artery. The patient was subsequently discharged on medical therapy but returned 3 days later due to worsening chest pain. Electrocardiogram revealed inferior and anteroseptal ST segment changes with peak troponin of 14.9 ng/ml (reference range <0.80 ng/ml). Coronavirus disease 2019 (COVID-19) nasopharyngeal swab was performed prior to urgent coronary angiogram. Coronary angiogram was performed with full personal protective equipment for respiratory and droplet precautions due to pending COVID-19 testing results. Angiogram revealed spontaneous coronary artery dissection (SCAD) extending from the ostium of the LAD to the distal vessel. COVID-19 testing returned positive while in intensive care unit. The patient was not a percutaneous coronary intervention candidate due to the extent of the dissection and was not a surgical candidate due to a lack of graftable target and medical management was continued. To our knowledge, this case is the first in which SCAD has been reported in the LAD in a patient with COVID-19 with no other symptoms of respiratory illness or symptoms classically associated with the novel coronavirus. SCAD should be considered on the differential as one of the various cardiac manifestations of COVID-19 infection.","Catheter Cardiovasc Interv","Kumar, Kris","Vogt, Joshua C","Divanji, Punag H","Cigarroa, Joaquin E","32383284"],"abstract":["A 48-year-old woman with a past medical history of migraines and hyperlipidemia presented due to severe retrosternal chest pain with no other associated signs or symptoms. The patient was hemodynamically stable and was found to have an elevated troponin with electrocardiogram showing no ischemic changes. Computed tomography of the coronary arteries showed a left dominant system with dissection extending from the mid-to-distal left anterior descending (LAD) artery. The patient was subsequently discharged on medical therapy but returned 3 days later due to worsening chest pain. Electrocardiogram revealed inferior and anteroseptal ST segment changes with peak troponin of 14.9 ng/ml (reference range <0.80 ng/ml). Coronavirus disease 2019 (COVID-19) nasopharyngeal swab was performed prior to urgent coronary angiogram. Coronary angiogram was performed with full personal protective equipment for respiratory and droplet precautions due to pending COVID-19 testing results. Angiogram revealed spontaneous coronary artery dissection (SCAD) extending from the ostium of the LAD to the distal vessel. COVID-19 testing returned positive while in intensive care unit. The patient was not a percutaneous coronary intervention candidate due to the extent of the dissection and was not a surgical candidate due to a lack of graftable target and medical management was continued. To our knowledge, this case is the first in which SCAD has been reported in the LAD in a patient with COVID-19 with no other symptoms of respiratory illness or symptoms classically associated with the novel coronavirus. SCAD should be considered on the differential as one of the various cardiac manifestations of COVID-19 infection."],"journal":"Catheter Cardiovasc Interv","authors":["Kumar, Kris","Vogt, Joshua C","Divanji, Punag H","Cigarroa, Joaquin E"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32383284","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/ccd.28960","keywords":["catheterization diagnostic","coronary angiography","coronary artery disease","coronary dissection"],"topics":["Case Report"],"weight":1,"_version_":1666419683298902016,"score":160.1906},{"pmid":32460364,"title":"Delayed Diagnosis of Pediatric Appendicitis during the COVID-19 Pandemic.","text":["Delayed Diagnosis of Pediatric Appendicitis during the COVID-19 Pandemic.","AIM: To present seven pediatric patients with appendicitis, all with late diagnosis resulting from different aspects of the fear from the current global COVID-19 pandemic. METHODS: Cases were collected from three pediatric surgical wards. Comparison between complicated appendicitis rates in the COVID-19 era and similar period in previous year was performed. RESULTS: All seven children presented with complicated appendicitis. Main reasons for the delayed diagnosis during the COVID-19 era were parental concern, telemedicine use and insufficient evaluation. Higher complication rates were found during the COVID-19 era compared to similar period in previous year (22% vs. 11%, p-value 0.06). CONCLUSION: The fear from COVID-19 pandemic may result in delayed diagnosis and higher complication rates in common pediatric medical conditions. We believe care givers as well as healthcare providers should not withhold necessary medical care since delay in diagnosis and treatment in these routinely seen medical emergencies may become as big of a threat as COVID-19 itself.","Acta Paediatr","Snapiri, Ori","Rosenberg Danziger, Chen","Krause, Irit","Kravarusic, Dragan","Yulevich, Alon","Balla, Uri","Bilavsky, Efraim","32460364"],"abstract":["AIM: To present seven pediatric patients with appendicitis, all with late diagnosis resulting from different aspects of the fear from the current global COVID-19 pandemic. METHODS: Cases were collected from three pediatric surgical wards. Comparison between complicated appendicitis rates in the COVID-19 era and similar period in previous year was performed. RESULTS: All seven children presented with complicated appendicitis. Main reasons for the delayed diagnosis during the COVID-19 era were parental concern, telemedicine use and insufficient evaluation. Higher complication rates were found during the COVID-19 era compared to similar period in previous year (22% vs. 11%, p-value 0.06). CONCLUSION: The fear from COVID-19 pandemic may result in delayed diagnosis and higher complication rates in common pediatric medical conditions. We believe care givers as well as healthcare providers should not withhold necessary medical care since delay in diagnosis and treatment in these routinely seen medical emergencies may become as big of a threat as COVID-19 itself."],"journal":"Acta Paediatr","authors":["Snapiri, Ori","Rosenberg Danziger, Chen","Krause, Irit","Kravarusic, Dragan","Yulevich, Alon","Balla, Uri","Bilavsky, Efraim"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32460364","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/apa.15376","keywords":["appendicitis","covid-19","children","corona virus","pediatric"],"locations":["appendicitis"],"topics":["Prevention"],"weight":1,"_version_":1667967698902974464,"score":138.62204}]}